7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone has been researched along with Bronchopulmonary Dysplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, M; Bejjani, BA; Bhatt, SS; Bolivar, J; Carter, NP; Cheung, SW; Driscoll, DJ; Durham-O'Donnell, J; Fitzgerald, T; Gribble, S; Hallam, L; Hustead, V; Kini, U; Knight, G; Langston, C; Maisenbacher, MK; Martin, V; Mascotti, K; McDonald-McGinn, D; McRae, D; Mehta, S; Murray, M; Newbury, R; Nicholson, AG; Nowaczyk, MM; Ou, Z; Patel, A; Paterson, J; Prigmore, E; Rajan, D; Schultz, R; Sen, P; Shaffer, LG; Shaikh, TH; Shaw-Smith, C; Simonic, I; Stankiewicz, P; Storer, M; Tyreman, M; Willatt, L; Wiszniewska, J; Xia, Z; Zackai, EH | 1 |
1 other study(ies) available for 7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations.
Topics: Abnormalities, Multiple; Bronchopulmonary Dysplasia; Capillaries; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 16; Doxorubicin; Female; Forkhead Transcription Factors; Gene Deletion; Gene Silencing; Humans; In Situ Hybridization, Fluorescence; Infant; Infant, Newborn; Male; Mutation; Pulmonary Alveoli; Pulmonary Veins | 2009 |